JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB33917

Anti-Rel B 抗体 [EP613Y]

Anti-Rel B antibody [EP613Y]

Be the first to review this product! Submit a review

|

(8 Publications)

Rabbit Recombinant Monoclonal Rel B antibody. Suitable for IHC-P, IP, WB, Flow Cyt (Intra) and reacts with Human samples. Cited in 8 publications.

別名を表示する

Transcription factor RelB, I-Rel, RELB

4 Images
Flow Cytometry (Intracellular) - Anti-Rel B antibody [EP613Y] (AB33917)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-Rel B antibody [EP613Y] (AB33917)

Intracellular Flow Cytometry analysis of Daudi (Human Burkitt's lymphoma lymphoblast) cells labeling Rel B (red) with ab33917 at a 1/2000 dilution. Cells were fixed with 4% paraformaldehyde and permeabilized with 90% methanol. A goat anti-rabbit IgG (Alexa Fluorr® 488) (ab150077) was used as the secondary antibody at a 1/2000 dilution. Black - Rabbit monoclonal IgG (Black) (ab172730). Blue (unlabeled control) - Cell without incubation with primary antibody and secondary antibody (Blue).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Rel B antibody [EP613Y] (AB33917)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Rel B antibody [EP613Y] (AB33917)

Immunohistochemical analysis of paraffin-embedded human lymphoma using ab33917

Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.

Immunoprecipitation - Anti-Rel B antibody [EP613Y] (AB33917)
  • IP

Lab

Immunoprecipitation - Anti-Rel B antibody [EP613Y] (AB33917)

Purified ab33917 at 1/50 dilution (2μg) immunoprecipitating Rel B in Raji whole cell lysate.
Lane 1 (input) : Raji (Human Burkitt's lymphoma B lymphocyte) whole cell lysate 10μg
Lane 2 (+) : ab33917 + Raji whole cell lysate.
Lane 3 (-) : Rabbit monoclonal IgG (ab172730) instead of ab33917 in Raji whole cell lysate.
VeriBlot for IP Detection Reagent (HRP) (ab131366) (1/1000 dilution) was used for Western blotting.
Blocking Buffer and concentration : 5% NFDM/TBST.
Diluting buffer and concentration : 5% NFDM/TBST.
Observed band size : 62 kDa

All lanes:

Immunoprecipitation - Anti-Rel B antibody [EP613Y] (ab33917)

Predicted band size: 62 kDa,85 kDa

false

Western blot - Anti-Rel B antibody [EP613Y] (AB33917)
  • WB

Unknown

Western blot - Anti-Rel B antibody [EP613Y] (AB33917)

All lanes:

Western blot - Anti-Rel B antibody [EP613Y] (ab33917) at 1/500 dilution

Lane 1:

Raji cell lysate at 10 µg

Lane 2:

Daudi cell lysate at 10 µg

Secondary

All lanes:

Goat anti-rabbit HRP labeled

Predicted band size: 62 kDa

false

関連する標識済み抗体及び組成の異なる製品 (3)

Key facts

宿主種

Rabbit

クローン性

Monoclonal

クローン番号

EP613Y

アイソタイプ

IgG

キャリアフリー

No

交差種

Human

アプリケーション

IP, Flow Cyt (Intra), WB, IHC-P

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

style
left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/250", "IHCP-species-notes": "<p></p>", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/50", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500", "WB-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1/2000", "FlowCytIntra-species-notes": "<p></p>" } } }
style
left-column

製品の詳細

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

style
left-column

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
バッファー組成
pH: 7.2 - 7.4 Preservative: 0.05% Sodium azide Constituents: 50% Tissue culture supernatant, 40% Glycerol (glycerin, glycerine), 9.85% Tris glycine
出荷温度
Blue Ice
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle
style
left-column

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

Rel B also known as RELB proto-oncogene is a member of the NF-κB family of transcription factors. This protein plays a significant role in regulating gene expression. Rel B has a molecular mass of approximately 68 kDa. It expresses in diverse tissues including lymphoid organs and epithelial cells. It generally resides in the cytoplasm and translocates to the nucleus upon activation.
Biological function summary

Rel B serves as a critical component of the alternative NF-κB signaling pathway. It often forms a complex with another NF-κB family member called p52. This complex controls the transcription of genes involved in the immune response cell survival and differentiation. Additionally Rel B contributes to the development of secondary lymphoid organs and modulation of immune responses.

Pathways

Rel B integrates into the non-canonical NF-κB signaling pathway also influencing the canonical pathway to a lesser extent. In the non-canonical pathway Rel B interacts with NIK and p100 to influence immune cell function. This involvement makes Rel B essential in processes like adaptive immunity and inflammatory responses. The protein p52 closely associates with Rel B aiding its activity in these pathways.

Rel B has connections to autoimmune diseases and certain cancers. Abnormal Rel B activity can lead to chronic inflammation and contribute to conditions like rheumatoid arthritis. In cancer its deregulation associates with lymphomas where it may interact with other NF-κB proteins like p50 and RelA affecting cell proliferation and survival. Understanding Rel B in these contexts could provide insights into therapeutic targets.
style
left-column
style
left-column

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:
style
left-column

ターゲットの情報

NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric RelB-p50 and RelB-p52 complexes are transcriptional activators. RELB neither associates with DNA nor with RELA/p65 or REL. Stimulates promoter activity in the presence of NFKB2/p49. As a member of the NUPR1/RELB/IER3 survival pathway, may provide pancreatic ductal adenocarcinoma with remarkable resistance to cell stress, such as starvation or gemcitabine treatment. Regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-BMAL1 heterodimer in a CRY1/CRY2 independent manner. Increased repression of the heterodimer is seen in the presence of NFKB2/p52. Is required for both T and B lymphocyte maturation and function (PubMed : 26385063).
See full target information RELB
style
left-column

文献 (8)

Recent publications for all applications. Explore the full list and refine your search

Proceedings of the National Academy of Sciences of the United States of America 121:e2321794121 PubMed39231201

2024

Inherited human RelB deficiency impairs innate and adaptive immunity to infection.

Applications

Unspecified application

Species

Unspecified reactive species

Tom Le Voyer,Majistor Raj Luxman Maglorius Renkilaraj,Kunihiko Moriya,Malena Pérez Lorenzo,Tina Nguyen,Liwei Gao,Tamar Rubin,Axel Cederholm,Masato Ogishi,Carlos A Arango-Franco,Vivien Béziat,Romain Lévy,Mélanie Migaud,Franck Rapaport,Yuval Itan,Elissa K Deenick,Irene Cortese,Andrea Lisco,Kaan Boztug,Laurent Abel,Stéphanie Boisson-Dupuis,Bertrand Boisson,Patrick Frosk,Cindy S Ma,Nils Landegren,Fatih Celmeli,Jean-Laurent Casanova,Stuart G Tangye,Anne Puel

Cell death discovery 8:285 PubMed35690612

2022

CircRFWD3 promotes HNSCC metastasis by modulating miR-27a/b/PPARγ signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Zihao Wei,Ying Wang,Jiakuan Peng,Honglin Li,Junjie Gu,Ning Ji,Taiwei Li,Xikun Zhou,Xin Zeng,Jing Li,Qianming Chen

Frontiers in immunology 12:678036 PubMed34305908

2021

Dectin-1 Controls TSLP-Induced Th2 Response by Regulating STAT3, STAT6, and p50-RelB Activities in Dendritic Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Chao Gu,Katherine Upchurch,Joshua Horton,Mathew Wiest,Sandra Zurawski,Mark Millard,Robert R Kane,HyeMee Joo,Lisa A Miller,SangKon Oh

Hematological oncology 35:187-197 PubMed26799990

2016

Comprehensive phenotypic characterization of PTLD reveals potential reliance on EBV or NF-κB signalling instead of B-cell receptor signalling.

Applications

Unspecified application

Species

Unspecified reactive species

Thomas Menter,Michael Dickenmann,Darius Juskevicius,Juerg Steiger,Stephan Dirnhofer,Alexandar Tzankov

Hematological oncology 32:72-81 PubMed23949965

2013

Phenotype profiling of primary testicular diffuse large B-cell lymphomas.

Applications

Unspecified application

Species

Unspecified reactive species

Thomas Menter,Martina Ernst,Julius Drachneris,Stephan Dirnhofer,Andre Barghorn,Philip Went,Alexandar Tzankov

The American journal of pathology 179:125-33 PubMed21703398

2011

Lung-targeted overexpression of the NF-κB member RelB inhibits cigarette smoke-induced inflammation.

Applications

Unspecified application

Species

Unspecified reactive species

David H McMillan,Carolyn J Baglole,Thomas H Thatcher,Sanjay Maggirwar,Patricia J Sime,Richard P Phipps

Investigative ophthalmology & visual science 52:230-6 PubMed20811049

2010

The nuclear-factor kappaB pathway is activated in pterygium.

Applications

Unspecified application

Species

Unspecified reactive species

Jay Jyh Kuen Siak,See Liang Ng,Li-Fong Seet,Roger W Beuerman,Louis Tong

Blood 115:1226-37 PubMed19965620

2009

Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type.

Applications

Unspecified application

Species

Unspecified reactive species

Yenlin Huang,Aurélien de Reyniès,Laurence de Leval,Bouchra Ghazi,Nadine Martin-Garcia,Marion Travert,Jacques Bosq,Josette Brière,Barbara Petit,Emilie Thomas,Paul Coppo,Teresa Marafioti,Jean-François Emile,Marie-Hélène Delfau-Larue,Christian Schmitt,Philippe Gaulard
View all publications
style
left-column
style
left-column
style
right-column

代替製品

Primary Antibodies

AB154957

Anti-Rel B antibody

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Rel B antibody (AB154957)

  • 0
  • 0
Primary Antibodies

AB235922

Anti-Rel B antibody

Immunocytochemistry/ Immunofluorescence - Anti-Rel B antibody (AB235922)

  • 0
  • 0
Primary Antibodies

AB212214

PE Anti-Rel B antibody [EP614Y]

RabMAb|Recombinant

Flow Cytometry (Intracellular) - PE Anti-Rel B antibody [EP614Y] (AB212214)

  • 0
  • 0
Primary Antibodies

AB217070

Alexa Fluor® 647 Anti-Rel B antibody [EP614Y]

RabMAb|Recombinant

Immunocytochemistry/ Immunofluorescence - Alexa Fluor® 647 Anti-Rel B antibody [EP614Y] (AB217070)

  • 0
  • 0
Primary Antibodies

AB33907

Anti-Rel B antibody [EP614Y]

RabMAb|Recombinant|KO Validated

Flow Cytometry (Intracellular) - Anti-Rel B antibody [EP614Y] (AB33907)

  • 0
  • 0

組合せ製品

Assay Kits

AB283878

Human Rel B ELISA Kit

Recombinant|SimpleStep

ELISA - Human Rel B ELISA Kit (AB283878)

  • 0
  • 0
Secondary Antibodies

AB150077

Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488)

Immunocytochemistry/ Immunofluorescence - Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) (AB150077)

  • 5
  • 20
Primary Antibodies

AB33905

Anti-Bcl10 antibody [EP606Y]

RabMAb|Recombinant|KO Validated

Flow Cytometry (Intracellular) - Anti-Bcl10 antibody [EP606Y] (AB33905)

  • 0
  • 0
Primary Antibodies

AB219620

Anti-MMP13 antibody [EPR21778]

RabMAb|Recombinant

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-MMP13 antibody [EPR21778] (AB219620)

  • 5
  • 1
Primary Antibodies

AB179483

Anti-HIF-1 alpha antibody [EPR16897]

RabMAb|Advanced Validation|Recombinant|KO Validated

Immunocytochemistry/ Immunofluorescence - Anti-HIF-1 alpha antibody [EPR16897] (AB179483)

  • 4
  • 9

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com